邻近类别 圖書 [1/1] 期刊論文 [327/330] 类别统计 近3年内发表的文件:16(8.94%) 含全文笔数:115(64.25%) 文件下载次数统计 下载大于0次:115(100.00%) 下载大于100次:112(97.39%) 全文下载总次数:39325(22.06%) 最后更新时间: 2024-12-01 10:33 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Single-cell RNA sequencing via Endo... Nivolumab plus ipilimumab (N plus I... Risk of type 2 diabetes mellitus an... Phase 1 studies of D07001-F4 and D0... Updated overall survival (OS) from ... Outcomes of post-immunotherapy dura... Updated overall survival (OS) from ... Updated results of the FOENIX-CCA2 ... Comparative genomic analysis and it... A phase II trial of nivolumab, gemc...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目101-125 / 179. (共8页) << < 1 2 3 4 5 6 7 8 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2016-02	Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	Oncology Research and Treatment. 2016 Feb;39(Suppl. 1):170.
2016-02	A randomized, open-label phase II study of nanoliposomal irinotecan (nal-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine in patients with previously untreated metastatic pancreatic adenocarcinoma (mPAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract TPS482.
2016-02	Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 417.
2016-02	Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 134.
2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
2015-12	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial	Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
2015-09	The safety and efficacy of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan	European Journal of Cancer. 2015 Sep;51(Suppl. 3):S459.
2015-09	Expression of the Helicobater pylori CagA protein is closely associated with Helicobater pylori-dependence of early-stage high-grade gastric lymphoma	European Journal of Cancer. 2015 Sep;51(Suppl. 3):S662.
2015-08	The association between periodontal disease and pancreatic cancer	Cancer Research. 2015 Aug;75:Abstract number 871.
2015-05	Heterogeneous cell origin of helicobater pylori-dependent high-grade gastric lymphomas	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e19520.
2015-05	Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4101.
2015-05	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
2015-01	Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	Journal of Clinical Oncology. 2015 Jan;33(3, Suppl. ):234.
2014-12	Pegylated arginine deiminase (ADI-PEG20) in relapsed/refractory and/or elder Acute Myeloid Leukemia: The preliminary result of phase II trial	Blood. 2014 Dec;124(21):984.
2014-10	Nuclear expression of BCL10 has a role in the regulation of cell growth and progression of pancreatic cancer through the activation of NF-kappa B-related signaling	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 4217.
2014-05	Using chinese herbal medicine containing mu-tong is associated with upper urinary tract cancer in patient with end-stage renal disease	Nephrology, Dialysis, Transplantation. 2014 May;29(Suppl. 3):iii65-iii67.
2014-05	Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):TPS4148.
2014-05	Association of helicobacter pylori CagA translocation with the expression of CagA-signaling transduction molecules in gastric mucosa-associated lymphoid tissue lymphoma	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):8571.
2014-05	High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522.
2014-05	A phase I dose escalation study of weekly BI 836845, a fully human, affinity-optineized, insulin -like growth factor (IGF) ligand neutralizing antibody, in patients with advanced solid cancers	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):2617.
2014-01	EVOLVE-1: Phase 3 study of everolimus for advanced HCC that progressed during or after sorafenib	Journal of Clinical Oncology. 2014 Jan;32(3 Suppl.):Abstract number 172
2014-01	Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial	Journal of Clinical Oncology. 2014 Jan;32(3 Suppl):Abstract number 267.
2013-05	Effective treatment of aggressive B-cell lymphomas by downregulated NIK-induced noncanonical NF-kappa B pathway activation through inhibition of BAFF	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e13554.
2013-05	KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 4018.

显示项目101-125 / 179. (共8页) << < 1 2 3 4 5 6 7 8 > >> 每页显示[10|25|50]项目